Healthcare investors and entrepreneurs need a constant crash course in their industries. Today’s medical device investors need to be as savvy in big data as they are in the next generation of stents.
Healthcare investing (doing it and getting it) is a tough terrain. But it’s also filled with new opportunities and partnerships. You just have to know where to find them.
We’ve got three keynotes at the MidAmerica Healthcare Venture Forum on March 10-11 in Chicago that are right in that wheelhouse: deep thinkers on health data and thoughtful leaders who are looking to innovate from their positions leading elite non-profit foundations and newly formed innovation divisions within Big Pharma.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
- Nancy Brown, CEO of the American Heart Association
- Chris Boone, Executive Director of the Health Data Consortium
- Naomi Fried, vice president of medical information, innovation & external partnerships at Biogen Idec
Join us in Chicago to listen and connect with these leaders as well as other experts in areas from precision medicine, drug and device commercialization, health insurance innovation and more. The MidAmerica Healthcare Venture Forum is the only national healthcare investing conference based in the Midwest and differentiated by unique insights and dealflow.
Our keynote speakers reflect the prominence of the conference.
Nancy Brown has since 2009 been chief executive officer of the American Heart Association, the world’s largest voluntary health organization dedicated to preventing, treating and defeating cardiovascular diseases and stroke. Under Brown’s leadership, the AHA has launched a plan to improve the cardiovascular health of all Americans by 20 percent by 2020. Brown also started major new initiatives including the Cardiovascular Genome Phenome Study and the Science & Technology Accelerator.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Chris Boone became the executive director of the Health Data Consortium in October, and is a recognized expert in health systems, health informatics, health IT policy, and the use of electronic clinical data to generate clinical and scientific evidence for public policy, quality improvement, and patient-centered outcomes research efforts. Before joining the Health Data Consortium, Chris was a vice president in Avalere Health’s evidence translation and implementation practice, where he focused on developing evidence generation strategies for professional medical societies, consumer advocacy groups, and life sciences companies.
Naomi Fried in December announced her move to Biogen Idec to launch new innovation initiatives. At Biogen Idec, she will focus on the multiple sclerosis and hemophilia patients that Biogen services, bu also find new ways to connect Biogen to both patients and physicians. Before joining Biogen Idec she served as chief innovation officer at Boston Children’s Hospital, where she created and built the Innovation Acceleration program, and lead a team to promote technological innovation, clinical-process innovation, and business model innovation across the institution.
We’ll add one more keynote soon – as well as unveil the 30 startup companies presenting at the event. Keep checking our agenda for new speakers and changes. I want to see you in Chicago; it’s the next natural stop after JP Morgan for anyone involved in launching or investing in the next great healthcare company.
Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].
